Mitsubishi Chemical has given Bain right of first refusal to negotiate sale of its subsidiary, Nikkei says-February 2024-www.financetom.com

Mitsubishi Chemical has given Bain right of first refusal to negotiate sale of its subsidiary, Nikkei says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Mitsubishi Chemical has given Bain right of first refusal to negotiate sale of its subsidiary, Nikkei says

Jan 20, 2025 2:30 AM

TOKYO, Jan 20 (Reuters) - Mitsubishi Chemical Group ( MTLHF ) has given

the U.S. investment fund Bain Capital the right of first refusal to negotiate

the sale of its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the Nikkei

reported on Monday.

Previous page： US court blocks Tapestry's $8.5 billion acquisition of rival Capri Next page： --Skechers U.S.A Guides For Q4 EPS of $0.70-$0.75 on Sales of $2.165-$2.215 Billion, vs CIQ Analyst Consensus of $0.76/Share on Sales of $2.215 Billion

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

US court blocks Tapestry's $8.5 billion acquisition of rival Capri

Nov 3, 2024

NEW YORK (Reuters) - A U.S. judge blocked the pending $8.5 billion merger of U.S. handbag and accessories maker Tapestry and Capri on Thursday, a victory for the U.S. Federal Trade Commission in an industry where merger challenges are rare. The FTC argued at an eight-day trial in New York that the merger would eliminate fierce head-to-head competition between the...

--Skechers U.S.A Guides For Q4 EPS of $0.70-$0.75 on Sales of $2.165-$2.215 Billion, vs CIQ Analyst Consensus of $0.76/Share on Sales of $2.215 Billion

Nov 3, 2024

04:11 PM EDT, 10/24/2024 (MT Newswires) -- Price: 68.00, Change: +6.36, Percent Change: +10.32 ...

UBS migration of Credit Suisse clients to take 18 months, CEO says

Nov 3, 2024

(Reuters) - The incipient migration of clients from Credit Suisse to UBS should take about another 18 months, UBS CEO Sergio Ermotti said on Thursday, as his bank presses on with the integration of its former rival. UBS acquired its longtime competitor last year after Credit Suisse collapsed due to a series of scandals and setbacks, and Ermotti has vowed...

--L3Harris Technologies Guides For 2024 EPS of $12.95-$13.15 on Revenue of $21.1-$21.3 Billion, vs CIQ Analyst Consensus of $13.04/Share on Revenue of $21.25 Billion

Nov 3, 2024

04:13 PM EDT, 10/24/2024 (MT Newswires) -- Price: 251.00, Change: +6.82, Percent Change: +2.79 ...